The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting

Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency...

Descripción completa

Detalles Bibliográficos
Autores principales: Corwin, Douglas S, Ender, Peter T, Sahu, Nitasa, Durgham, Ryan A, McGorry, Dennis M, Rahman, Awan, Stoltzfus, Jill, Jahre, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272954/
https://www.ncbi.nlm.nih.gov/pubmed/34258324
http://dx.doi.org/10.1093/ofid/ofab305
_version_ 1783721287923793920
author Corwin, Douglas S
Ender, Peter T
Sahu, Nitasa
Durgham, Ryan A
McGorry, Dennis M
Rahman, Awan
Stoltzfus, Jill
Jahre, Jeffrey A
author_facet Corwin, Douglas S
Ender, Peter T
Sahu, Nitasa
Durgham, Ryan A
McGorry, Dennis M
Rahman, Awan
Stoltzfus, Jill
Jahre, Jeffrey A
author_sort Corwin, Douglas S
collection PubMed
description Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality.
format Online
Article
Text
id pubmed-8272954
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82729542021-07-12 The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting Corwin, Douglas S Ender, Peter T Sahu, Nitasa Durgham, Ryan A McGorry, Dennis M Rahman, Awan Stoltzfus, Jill Jahre, Jeffrey A Open Forum Infect Dis Brief Reports Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency department visits among high-risk outpatients with mild to moderate COVID-19 illness and reveals a trend toward improved mortality. Oxford University Press 2021-06-10 /pmc/articles/PMC8272954/ /pubmed/34258324 http://dx.doi.org/10.1093/ofid/ofab305 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Reports
Corwin, Douglas S
Ender, Peter T
Sahu, Nitasa
Durgham, Ryan A
McGorry, Dennis M
Rahman, Awan
Stoltzfus, Jill
Jahre, Jeffrey A
The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting
title The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting
title_full The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting
title_fullStr The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting
title_full_unstemmed The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting
title_short The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting
title_sort efficacy of bamlanivimab in reducing emergency department visits and hospitalizations in a real-world setting
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272954/
https://www.ncbi.nlm.nih.gov/pubmed/34258324
http://dx.doi.org/10.1093/ofid/ofab305
work_keys_str_mv AT corwindouglass theefficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT enderpetert theefficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT sahunitasa theefficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT durghamryana theefficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT mcgorrydennism theefficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT rahmanawan theefficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT stoltzfusjill theefficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT jahrejeffreya theefficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT corwindouglass efficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT enderpetert efficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT sahunitasa efficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT durghamryana efficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT mcgorrydennism efficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT rahmanawan efficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT stoltzfusjill efficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting
AT jahrejeffreya efficacyofbamlanivimabinreducingemergencydepartmentvisitsandhospitalizationsinarealworldsetting

Ejemplares similares